191 related articles for article (PubMed ID: 37996685)
1. Relevance of the Entry by Fusion at the Cytoplasmic Membrane vs. Fusion After Endocytosis in the HIV and SARS-Cov-2 Infections.
Huerta L; Gamboa-Meraz A; Estrada-Ochoa PS
Results Probl Cell Differ; 2024; 71():329-344. PubMed ID: 37996685
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 entry in SupT1-R5, CEM-ss, and primary CD4+ T cells occurs at the plasma membrane and does not require endocytosis.
Herold N; Anders-Ößwein M; Glass B; Eckhardt M; Müller B; Kräusslich HG
J Virol; 2014 Dec; 88(24):13956-70. PubMed ID: 25253335
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion.
de la Vega M; Marin M; Kondo N; Miyauchi K; Kim Y; Epand RF; Epand RM; Melikyan GB
Retrovirology; 2011 Dec; 8():99. PubMed ID: 22145853
[TBL] [Abstract][Full Text] [Related]
4. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.
Miyauchi K; Kim Y; Latinovic O; Morozov V; Melikyan GB
Cell; 2009 May; 137(3):433-44. PubMed ID: 19410541
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.
Sisk JM; Frieman MB; Machamer CE
J Gen Virol; 2018 May; 99(5):619-630. PubMed ID: 29557770
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.
Seyedpour S; Khodaei B; Loghman AH; Seyedpour N; Kisomi MF; Balibegloo M; Nezamabadi SS; Gholami B; Saghazadeh A; Rezaei N
J Cell Physiol; 2021 Apr; 236(4):2364-2392. PubMed ID: 32901936
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
[TBL] [Abstract][Full Text] [Related]
9. Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion.
Thakur N; Conceicao C; Isaacs A; Human S; Modhiran N; McLean RK; Pedrera M; Tan TK; Rijal P; Townsend A; Taylor G; Young PR; Watterson D; Chappell KJ; Graham SP; Bailey D
J Gen Virol; 2021 Jan; 102(1):. PubMed ID: 33054904
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus internalization into epithelial cells requires Na+/H+ exchangers and p21-activated kinases but neither clathrin- nor caveolin-mediated endocytosis.
Devadas D; Koithan T; Diestel R; Prank U; Sodeik B; Döhner K
J Virol; 2014 Nov; 88(22):13378-95. PubMed ID: 25210183
[TBL] [Abstract][Full Text] [Related]
12. Role of host factors in SARS-CoV-2 entry.
Evans JP; Liu SL
J Biol Chem; 2021 Jul; 297(1):100847. PubMed ID: 34058196
[TBL] [Abstract][Full Text] [Related]
13. Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
Sengar A; Cervantes M; Bondalapati ST; Hess T; Kasson PM
J Virol; 2023 May; 97(5):e0199222. PubMed ID: 37133381
[TBL] [Abstract][Full Text] [Related]
14. Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo.
Kumar N; Taily IM; Singh C; Kumar S; Rajmani RS; Chakraborty D; Sharma A; Singh P; Thakur KG; Varadarajan R; Ringe RP; Banerjee P; Banerjee I
PLoS Pathog; 2023 May; 19(5):e1011358. PubMed ID: 37126530
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
[TBL] [Abstract][Full Text] [Related]
16. [Entry process of enveloped viruses to host cells].
Miyauchi K
Uirusu; 2009 Dec; 59(2):205-13. PubMed ID: 20218329
[TBL] [Abstract][Full Text] [Related]
17. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
18. Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host.
Caccuri F; Messali S; Bortolotti D; Di Silvestre D; De Palma A; Cattaneo C; Bertelli A; Zani A; Milanesi M; Giovanetti M; Campisi G; Gentili V; Bugatti A; Filippini F; Scaltriti E; Pongolini S; Tucci A; Fiorentini S; d'Ursi P; Ciccozzi M; Mauri P; Rizzo R; Caruso A
Virus Evol; 2022; 8(1):veac042. PubMed ID: 35706980
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.
Burkard C; Verheije MH; Wicht O; van Kasteren SI; van Kuppeveld FJ; Haagmans BL; Pelkmans L; Rottier PJ; Bosch BJ; de Haan CA
PLoS Pathog; 2014 Nov; 10(11):e1004502. PubMed ID: 25375324
[TBL] [Abstract][Full Text] [Related]
20. The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components.
Laliberte JP; Weisberg AS; Moss B
PLoS Pathog; 2011 Dec; 7(12):e1002446. PubMed ID: 22194690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
